罗非鱼无乳链球菌LrrG-Sip融合蛋白免疫原性研究

为探究无乳链球菌LrrG(Leucine—rich repeat protein from GBS)和表面免疫原性蛋白Sip(surface immunogenic protein)串联表达的LrrG—Sip重组融合蛋白的免疫原性,该研究将原核表达的LrrG—Sip重组融合蛋白分别以0.5μg·g-1(R1组)、1.0μg·g-1(R2组)和1.5μg·g-1(R3组)每尾200μL腹腔注射免疫尼罗罗非鱼(Oreochromis niloticus),同时以Sip蛋白(s组)、LrrG蛋白(L组)以及PBS(P组)作为对照。2周后对所有免疫鱼体进行无乳链球菌(Streptococcus aga...

Full description

Saved in:
Bibliographic Details
Published in南方水产科学 Vol. 13; no. 3; pp. 51 - 57
Main Author 曾祖聪 可小丽 卢迈新 刘志刚 曹建萌 高风英 朱华平 王淼
Format Journal Article
LanguageChinese
Published 中国水产科学研究院珠江水产研究所,农业部热带亚热带水产资源利用与养殖重点实验室,广东 广州 510380 2017
上海海洋大学水产与生命学院,上海 201306%中国水产科学研究院珠江水产研究所,农业部热带亚热带水产资源利用与养殖重点实验室,广东 广州 510380
Subjects
Online AccessGet full text
ISSN2095-0780
DOI10.3969/j.issn.2095-0780.2017.03.007

Cover

More Information
Summary:为探究无乳链球菌LrrG(Leucine—rich repeat protein from GBS)和表面免疫原性蛋白Sip(surface immunogenic protein)串联表达的LrrG—Sip重组融合蛋白的免疫原性,该研究将原核表达的LrrG—Sip重组融合蛋白分别以0.5μg·g-1(R1组)、1.0μg·g-1(R2组)和1.5μg·g-1(R3组)每尾200μL腹腔注射免疫尼罗罗非鱼(Oreochromis niloticus),同时以Sip蛋白(s组)、LrrG蛋白(L组)以及PBS(P组)作为对照。2周后对所有免疫鱼体进行无乳链球菌(Streptococcus agalactiae)人工攻毒,攻毒剂量为其半致死浓度(LD50:4.0×10^8CFU·mL-1)。结果显示LrG—Sip重组融合蛋白R1组对尼罗罗非鱼的相对免疫保护率最高,达89.14%;且免疫后第14和第28天,该组鱼体血清抗体OD450nm值分别达0.63和0.64,均显著高于单一蛋白对照组(S和L组)和PBS组(P〈0.05);R1组鱼体血清过氧化物酶(POD)和碱性磷酸酶(AKP)活性在上述2个时间点也显著高于其他组(P〈0.05);但溶菌酶(LZM)和总超氧化物歧化酶(T—SOD)活性与其他组之间差异不显著(P〉0.05)。初步表明LrrG-Sip重组融合蛋白具有良好的免疫原性,其免疫原性明显优于单个蛋白,且能有效减少免疫剂量。
Bibliography:ZENG Zucong1,2, KE Xiaoli1 , LU Maixin1 , LIU Zhigang1 , CAO Jianmeng 1 , GAO Fengying1 , ZHU Huaping1 , WANG Miao1 ( 1. Key Lab. of Tropical & Subtropical Fishery Resource Application & Cultivation, Ministry of Agriculture; Pearl River Fisheries Research Institute, Chinese Academy of Fisheries Science, Guangzhou 510380, China; 2. College of Fisheries & Life Science, Shanghai Ocean University, Shanghai 201306, China)
Streptococcus agalactiae; tilapia; LrrG-Sip recombinant fusion protein; immunogenicity
44-1683/S
To evaluate the immunogenicity of LrrG-Sip recombinant fusion protein, we immunized Nile tilapia (Oreochromis niloticus) by intraperitoneal (IP) injection with 200 μL LrrG-Sip recombinant fusion protein at dose of 0. 5 μg ·g-1 ( R1 group), 1.0 μg ·g-1 (R2 group) and 1.5 μg·g-1 (R3 group), respectively. Meanwhile, control groups of Nile tilapia were IP injected with 200 μL Sip protein ( 1.0 μg·g-1, S group), 200 μL LrrG protein ( 1.0 μg·g-1, L group) and 200 ixL sterile phosphate buffered saline ( PBS, P
ISSN:2095-0780
DOI:10.3969/j.issn.2095-0780.2017.03.007